SUSQUEHANNA INTERNATIONAL GROUP, LLP - ALEXZA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ALEXZA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$33,000
+32.0%
67,510
+85.6%
0.00%
Q4 2015$25,000
+47.1%
36,367
+177.6%
0.00%
Q3 2015$17,000
-58.5%
13,100
-34.5%
0.00%
Q1 2015$41,000
-89.6%
20,000
-92.4%
0.00%
Q4 2014$394,000
-38.3%
263,958
-3.8%
0.00%
Q3 2014$639,000
-48.2%
274,296
+1.7%
0.00%
Q2 2014$1,233,000
-17.7%
269,800
-20.3%
0.00%
Q1 2014$1,499,000
+4.7%
338,471
+11.8%
0.00%
-100.0%
Q4 2013$1,432,000
-36.8%
302,797
-31.6%
0.00%0.0%
Q3 2013$2,265,000
+10.5%
442,400
-6.4%
0.00%0.0%
Q2 2013$2,050,000472,4000.00%
Other shareholders
ALEXZA PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
LANSDOWNE PARTNERS AUSTRIA GMBH 1,212,555$5,262,000100.00%
HOWARD HUGHES MEDICAL INSTITUTE 98,914$429,0000.14%
Rotella Capital Management, Inc. 10,000$43,0000.14%
BBT Capital Management, LLC 132,533$575,0000.03%
Jefferies Group LLC 477,500$2,072,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 246,473$1,070,0000.02%
LANSDOWNE PARTNERS LIMITED PARTNERSHIP 307,500$1,335,0000.02%
FEDERATED HERMES, INC. 674,300$2,926,0000.01%
KNIGHT CAPITAL GROUP LLC 61,466$265,0000.01%
CREDIT SUISSE AG/ 654,292$2,839,0000.00%
View complete list of ALEXZA PHARMACEUTICALS INC shareholders